ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Nov 14, 2024 CURRENT REPORT
10-Q Nov 14, 2024 QUARTERLY REPORT
8-K Nov 4, 2024 CURRENT REPORT
424B4 Oct 25, 2024 PROSPECTUS SUPPLEMENT
8-K Oct 18, 2024 CURRENT REPORT
8-K Sep 10, 2024 CURRENT REPORT
8-K Aug 20, 2024 CURRENT REPORT
424B4 Aug 16, 2024 PROSPECTUS SUPPLEMENT
424B4 Aug 16, 2024 PROSPECTUS SUPPLEMENT
424B4 Aug 16, 2024 PROSPECTUS SUPPLEMENT
8-K Aug 15, 2024 CURRENT REPORT
10-Q Aug 14, 2024 QUARTERLY REPORT
424B5 Aug 7, 2024 PROSPECTUS SUPPLEMENT
424B5 Aug 7, 2024 PROSPECTUS SUPPLEMENT
EFFECT Aug 1, 2024
POS AM Jul 26, 2024 POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1
8-K Jul 23, 2024 CURRENT REPORT
8-K Jul 12, 2024 CURRENT REPORT
424B4 Jul 12, 2024 PROSPECTUS
EFFECT Jul 1, 2024
CORRESP Jun 27, 2024
UPLOAD Jun 26, 2024
8-K/A Jun 25, 2024 AMENDMENT NO. 1 TO FORM 8-K
8-K/A Jun 24, 2024 AMENDMENT NO. 1 TO FORM 8-K
S-1 Jun 21, 2024 REGISTRATION STATEMENT
← Newer Page 4 of 32 · 793 filings Older →